Caxton Associates LLP Adma Biologics, Inc. Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
A detailed history of Caxton Associates LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caxton Associates LLP holds 33,664 shares of ADMA stock, worth $610,664. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,664Holding current value
$610,664% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$338 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$306 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$233 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$208 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$103 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.56B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...